Fibromatoses

Modern Soft Tissue Pathology: Tumors and Non-Neoplastic Conditions

Volumn , Issue , 2010, Pages 238-254

  Miettinen, Markku ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012225077     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511781049.009     Document Type: Chapter

References (79)

1. Ross DC. Epidemiology of Dupuytren’s disease. Hand Clin 1999; 15: 53-62.
2. Gudmundsson KG, Arngrimsson R, Sigfusson N, Bjornsson A, Jonsson T. Epidemiology of Dupuytren’s disease: Clinical, serological, and social assessment. The Reykjavik study. J Clin Epidemiol 2000; 53: 291-296.
3. Benson LS, Williams CS, Kahle M. Dupuytren’s contracture. J Am Acad Orthop Surg 1998; 6: 24-35.
4. Rayan GM. Dupuytren disease: Anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 2007; 89: 189-198.
5. Fetsch JF, Laskin WB, Miettinen M. Palmar-plantar fibromatosis in children and preadoleascents: A clinicopathological study of 56 cases with newly recognized demographics and extended follow-up information. Am J Surg Pathol 2005; 29: 1095-1105.
6. Allen PW. The fibromatoses: A clinicopathologic classification based on 140 cases. Am J Surg Pathol 1977; 1: 255-270.
7. Ushijima M, Tsuneyoshi M, Enjoji M. Dupuytren type fibromatoses:A clinicopathologic study of 62 cases. Acta Pathol Jpn 1984; 34: 991-1001.
8. Hueston JT. Some observations on knuckle pads. JHand Surg [Br] 1984; 9: 75-78.
9. Aluisio FV, Mair SD, Hall RL. Plantar fibromatosis: Treatment of primary and recurrent lesions and factors associated with recurrence. Foot Ankle Int 1996; 17: 672-678.
10. Zgonis T, Jolly GP, Polyzois V, Kanuck DM, Stamatis ED. Plantar fibromatosis. Clin Podiatr Med Surg North Am 2005; 22: 11-18.
11. Chen KT, van Dyne DA. Familial plantar fibromatosis. J Surg Oncol 1985; 29: 240-241.
12. Graells Estrada J., Garcia Fernandez D, Badina Tottoella F, Moreno Carzano A. Familial plantar fibromatosis. Clin Exp Dermatol 2003; 28: 669-670.
13. Luck JV. Dupuytren’s contracture: A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am 1959; 41: 635-664.
14. Evans HL. Multinucleated giant cell in plantar fibromatosis. Am J Surg Pathol 2002; 26: 244-248.
15. de Palma L, Santucci A, Gigante A, Di Giulio A, Carloni S. Plantar fibromatosis: An immunohistochemical and ultrastructural study. Foot Ankle Int 1999; 20: 253-257.
16. Dal Cin P., De Smet L, Sciot R, van Damme B, Van Den Berghe H. Trisomy 7 and trisomy 8 in dividing and nondividing tumor cells in Dupuytren’s disease. Cancer Genet Cytogenet 1999; 108: 137-140.
17. Casalone R, Mazzola D, Meroni E, Righi R, Minelli E, Granata P, et al. Cytogenetic and interphase cytogenetic analyses reveal chromosome instability but no clonal trisomy 8 in Dupuytren contracture. Cancer Genet Cytogenet 1997; 99: 73-76.
18. De Wever I., dal Cin P, Fletcher CDM, Mandahl N, Mertens F, Mitelman F, et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: A report from the CHAMP study group. Mod Pathol 2000; 13: 1080-1085.
19. Breiner JA, Nelson M, Bredthauer BD, Neff JR, Bridge JA. Trisomy 8 and trisomy 14 in plantar fibromatosis. Cancer Genet Cytogenet 1999; 108: 176-177.
20. Sawyer JR, Sammartino G, Godden N, Nicholas RW. A clonal reciprocal t(2;7)(p13;p13) in plantar fibromatosis. Cancer Genet Cytogenet 2005; 158: 67-69.
21. Chansky HA, Trumble TE, Conrad EU, Wolff JF, Murray LW, Raskind WH. Evidence for a polyclonal etiology of palmar fibromatosis. J Hand Surg 1999; 24: 339-344.
22. Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatosis are genetically distinct from deep fibromatosis. Mod Pathol 2001; 14: 695-701.
23. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, Ricci F, Weber K, Furlong MA, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005; 29: 653-659.
24. Sommer F, Schwarzer U, Wassmer G, Block W, Braun M, Klotz T, et al. Epidemiology of Peyronie’s disease. Int J Impot Res 2002; 14: 379-383.
25. Hellstrom WJ, Bivalaqua TJ. Peyronie’s disease: Etiology, medical and surgical therapy. J Androl 2000; 21: 347-354.
26. Smith BH. Peyronie’s disease. Am J Clin Pathol 1966; 43: 670-678.
27. DavisCJ Jr. Themicroscopic pathology of Peyronie’s disease. J Urol 1997; 157: 282-284.
28. Ferenc T, Sygut J, Kopczynski J, Mayer M, Latos-Bielenska A, Dziki A, et al. Aggressive fibromatosis (desmoid tumors):Definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol 20006; 57: 5-15.
29. Reitamo JJ, Häyry P, Nykyri E, Sax`en E. The desmoid tumor. I. Incidence, sex-, age and anatomical distribution in the Finnish population. Am J Clin Pathol 1982; 77: 665-673.
30. Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PWT, et al. Optimizing treatment of desmoid tumors. J Clin Oncol 2007; 25: 1785-1791.
31. Fallen T, Wilson M, Morlan B, Lindor NM. Desmoid tumors - a characterization of patients seen at Mayo clinic 1976-1999. Fam Cancer 2006; 5: 191-194.
32. Heiskanen I, Järvinen H. Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment. Int J Colorectal Dis 1996; 11: 157-162.
33. Posner MC, Shiu MH, Newsome JL, Hajdu SI, Gaynor JJ, Brennan MF. The desmoid tumor. Not a benign disease. Arch Surg 1989; 124: 191-196.
34. Brasfield RD. Das Gupta TK. Desmoid tumors of the anterior abdominal wall. Surgery 1969; 65: 241-246.
35. Häyry P, Reitamo JJ, Totterman S, Hopfner-Hallikainen D, Sivula A. The desmoid tumor. II. Analysis of factors possibly contributing to the etiology and growth behavior. Am J Clin Pathol 1982; 77: 674-680.
36. Pignatti G, Barbanti-Brodano G, Ferrari D, Gherlinzoni F, Bertoni F, Bacchni P, et al. Extra-abdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res 2000; 375: 207-213.
37. Gronchi A, Casali PG, Mariani L, Lo Vullo S, Colecchia M, Lozza L, et al. Quality of surgery and outcome in extraabdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. JClinOncol 2003; 21: 1390-1397.
38. Merchant NB, Lewis JJ, Woodruff JM, Leung DH, Brennan MF. Extremity and trunk desmoid tumors. Cancer 1999; 86: 2045-2052.
39. Hosalkar HS, Fox EJ, Delaney T, Torbert JT, Ogilvie CM, Lackman RD. Desmoid tumors and current status of management. Orthop Clin North Am 2006; 37: 53-63.
40. Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster AR. Extra-abdominal desmoid tumors. J Bone Joint Surg Am 1984; 66: 1369-1374.
41. Abraham SC, Reynolds C, Lee JH, Montgomery EA, Baisden BL, Krasinskas AM, Wu TT. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 2002; 33: 39-46.
42. Aaron AD, O’Mara JW, Legendre KE, Evans SR, Attinger CE, Montgomery EA. Chest wall fibromatosis associated with silicone implants. Surg Oncol 1996; 5: 93-99.
43. Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intara-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol 1990; 14: 335-341.
44. Sturt NJH, Clark SK. Current ideas in desmoid tumors. Fam Cancer 2000; 5: 275-285.
45. Burke AP, Sobin LH, Shekitka KM. Mesenteric fibromatosis:A follow-up study. Arch Pathol Lab Med 1990; 114: 832-835.
46. Mariani A, Nascimento AG, Webb MJ, Sim FH, Podratz KC. Surgical management of desmoid tumors of the female pelvis. J Am Coll Surg 2000; 191: 175-183.
47. Zayid I, Dihmis C. Familial multicentric fibromatosis - desmoids. Cancer 1969; 24: 786-795.
48. Reis-Filho JS, Milanezi F, Pope ZB, Fillus-Neto J, Schmitt FC. Primary fibromatosis of the breast in a patient with multiple desmoid tumors. Pathol Res Pract 2001; 197: 775-779.
49. Biermann JS. Desmoid tumors. Curr Treat Options Oncol 2000; 1: 262-262.
50. Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006; 24: 1195-1203.
51. Enzinger FM, Shiraki M. Musculo-aponeurotic fibromatosis of the shoulder girdle (extra-abdominal desmoid): Analysis of 30 cases followed-up for 10 or more years. Cancer 1967; 20: 1131-1140.
52. Ng TL, Gown AM, Barry TS, Cheang MC, Chan AK, Turbin DA, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005; 18: 68-74.
53. Carlson JW, Fletcher CDM. Imunohistochemivsry for β- catenin in the differential diagnosis of spindle cell lesions: Analysis of a series and review of the literature. Histopathology 2007; 51: 509-514.
54. Saito T, Oda Y, Tanaka K, Matsuda S, Tamiya S, Iwamoto Y, et al. β-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumors. J Pathol 2001; 195: 222-228.
55. Deyrup A, Tretiakova M, Montag AG. Estrogen receptor-β expression in extraabdominal fibromatoses: An analysis of 40 cases. Cancer 2006; 106: 208-213.
56. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006; 101: 385-398.
57. Okamoto Miyaki M., Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, et al. Coexistence of somatic and germ-line mutations in APC gene in desmoid tumors from patients with familial adenomatous polyposis. Cancer Res 1993; 53: 5079-5082.
58. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Tanaka K, Takahashi H, et al. Coexistence of somatic and germ-line mutations of APC gene in desmoid tumors from patients with familial adenomatous plyposis. Cancer Res 1993; 53: 5079-5082.
59. Couture J, Mitri A, Lagace R, Smits R, Berk T, Bouchard HL, et al. A germline mutation at the extreme 3' end of the APC gene results in a severe desmoid phenotype and is associated with overexpression of beta-catenin in the desmoid tumor. Clin Genet 2000; 57: 205-212.
60. Latchford A, Volikos E, Johnson V, Rogers P, Suraweera N, Tomlinson I, et al. APC mutations in FAP-associated desmoid tumours are non-random but not "just right." Hum Mol Genet 2007;16:78-82.
61. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin egulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol 1998; 153: 709-714.
62. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somaticAPCmutations in sporadic aggressive fibromatosis. Am J Pathol 1997; 151: 329-334.
63. Tejpar S, Nollet F, Li C, Wunder JS, Michils G, dal Cin P, et al. Predominance of beta-catenin mutations and betacatenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999; 18: 6615-6620.
64. Miyoshi Y, Iwao K, Nawa G, Ochi T, Nakamura Y. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res 1998; 10: 591-594.
65. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol 1996; 27: 939-943.
66. Alman BA, Pajerski ME, Diaz-Cano S, Corboy K, Wolfe HJ. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol 1997; 6: 98-101.
67. Lucas DR, Schroyer KR, McCarthy PJ, Markham NE, Fujita M, Enomoto TE. Desmoid tumor is a clonal cellular proliferation:PCR-amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol 1997; 21: 306-311.
68. Middleton SB, Frayling IM, Phillips RKS. Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer 2000; 82: 827-832.
69. Yoshida MA, Ikeuchi T, Iwama T, Miyaki M, Mori T, Ushijima Y, et al. Chromosome changes in desmoid tumors developed in patients with familial adenomatous polyposis. Jpn J Cancer Res 1991; 82: 916-921.
70. Dal Cin P., Sciot R, Aly MS, Delabie J, Stas M, de Wever I, et al. Some desmoid tumors are characterized by trisomy 8. Genes Chromosomes Cancer 1994; 10: 131-135.
71. Fletcher JA, Naeem R, Xiao S, Corson JM. Chromosome aberrations in desmoid tumors: Trisomy 8 may be a predictor of recurrence. Cancer Genet Cytogenet 1995; 79: 139-143.
72. Mertens F, Willen H, Rydholm A, Brosjo O, Carlen B, Mitelman F, et al. Trisomy 20 is a primary chromosome aberration in desmoid tumors. Int J Cancer 1995; 63: 527-529.
73. Qi H, DalCin P, Hernandez JM, Garcia JL, Sciot R, Fletcher C, et al. Trisomies 8 and 20 in desmoid tumors. Cancer Genet Cytogenet 1996; 92: 147-149.
74. Kouho H, Aoki T, Hisaoka M, Hashimoto H. Clinicopathological and interphase cytogenetic analysis of desmoid tumors. Histopathology 1997; 31: 336-341.
75. De Wever I., Dal Cin P, Fletcher CD, Mandahl N, Mertens F, Mitelman F, et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: A report from the CHAMP study group. Mod Pathol 2000;p13;1080-1085.
76. Bridge JA, Sreekantaiah C, Mouron B, Neff JR, Sandberg AA, and Wolman SR. Clonal chromosomal abnormalities in desmoid tumors. Cancer 1992; 69: 430-436.
77. Karlsson I, Mandahl N, Heim S, Rydholm A, Willen H, Mitelman F. Complex chromosome rearrangements in an extraabdominal desmoid tumor. Cancer Genet Cytogenet 1988; 34: 241-245.
78. Larramendy ML, Virolainen M, Tukiainen E, Elomaa I, Knuutila S. Chromosome band 1q21 is recurrently gained in desmoid tumors. Genes Chromosomes Cancer 1998; 23: 183-186.
79. Brandal P, Micci F, Bjerkehagen B, Eknaes M, Larramendy M, Lothe RA, et al, Heim S. Molecular cytogenetic characterization of desmoid tumors. Cancer Genet Cytogenet 2003; 146: 1-7.